Sun Dangze, Ding Chao, Dang Liyun, Yue Xiaotong, Wu Weitong, Wang Bei
Department of Thoracic Surgery, Xi 'an Chest Hospital, Xi'an, 710061, China.
Heliyon. 2024 Aug 8;10(16):e35939. doi: 10.1016/j.heliyon.2024.e35939. eCollection 2024 Aug 30.
This retrospective intention-to-treat study aims to identify risk factors associated with intraoperative conversion from Video-Assisted Thoracoscopic Surgery (VATS) Decortication to open thoracotomy in patients with Stage III Tuberculous Empyema, specifically focusing on non-Multi-Drug Resistant (MDR)/Extensively Drug-Resistant (XDR) cases.
The study included 122 patients with non-MDR/XDR tuberculous empyema who were initially scheduled for VATS decortication. Patients were divided into two groups: the Thoracoscopy group (n = 64), who successfully underwent VATS decortication, and the Conversion group (n = 58), who required intraoperative conversion to open thoracotomy. Complex cases were excluded from the study. The analysis focused solely on factors leading to conversion, rather than overall treatment outcomes.
A notable difference was observed in the rate of regular preoperative glucocorticoid utilization between the two cohorts, with the Conversion group exhibiting a lower percentage (46.5 %) in comparison to the Thoracoscopy group (75.0 %). Furthermore, the Thoracoscopy group displayed a significantly reduced frequency of ipsilateral lung abnormalities prior to the surgery (37.5 %), as opposed to that of the Conversion group (65.5 %). Multivariate logistic regression analysis revealed that the regular preoperative glucocorticoid use (odds ratio (OR) = 3.444, 95 % confidence interval (CI): 1.602-7.407) and pre-existing pulmonary lesions (OR = 0.31, 95%CI: 0.150-0.663) were potential influential factors.
Inconsistent preoperative glucocorticoid administration and ipsilateral lung lesions were identified as exacerbating factors leading to the complexity of VATS decortication by causing intraoperative pulmonary tissue contusion or hemorrhage, thus hindering the successful completion of VATS decortication and necessitating a conversion to thoracotomy. Awareness of these factors can aid surgeons in making well-informed decisions regarding the preoperative surgical approach.
这项回顾性意向性治疗研究旨在确定与Ⅲ期结核性脓胸患者术中从电视辅助胸腔镜手术(VATS)剥脱术转为开胸手术相关的危险因素,特别关注非耐多药(MDR)/广泛耐药(XDR)病例。
该研究纳入了122例最初计划接受VATS剥脱术的非MDR/XDR结核性脓胸患者。患者分为两组:胸腔镜组(n = 64),成功接受了VATS剥脱术;转换组(n = 58),术中需要转为开胸手术。复杂病例被排除在研究之外。分析仅关注导致转换的因素,而非总体治疗结果。
两组患者术前常规使用糖皮质激素的比例存在显著差异,转换组(46.5%)低于胸腔镜组(75.0%)。此外,胸腔镜组术前同侧肺部异常的发生率(37.5%)明显低于转换组(65.5%)。多因素逻辑回归分析显示,术前常规使用糖皮质激素(比值比(OR)= 3.444,95%置信区间(CI):1.602 - 7.407)和既往肺部病变(OR = 0.31,95%CI:0.150 - 0.663)是潜在的影响因素。
术前糖皮质激素给药不一致和同侧肺部病变被确定为导致VATS剥脱术复杂性的加重因素,它们会引起术中肺组织挫伤或出血,从而阻碍VATS剥脱术的成功完成,需要转为开胸手术。认识到这些因素有助于外科医生在术前手术方法上做出明智的决策。